Evidence map›Paper›PMID 41068077›Full record

ArticleNature communications2025

Stereoselective diversification of α-amino acids enabled by N-heterocyclic carbene catalysis.

Hong Zhang, Yuxing Cai, Yuqi Fang, Yong Huang, Jiean Chen

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hong Zhang *Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China.
Yuxing Cai *Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.
Yuqi Fang *Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China.
Yong HuangDepartment of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China. yonghuang@ust.hk.ORCID http://orcid.org/0000-0001-8377-8923
Jiean ChenPingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China. chenja@szbl.ac.cn.ORCID http://orcid.org/0000-0003-0703-5831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chiral α-amino acids (AAs), essential to biological systems and drug design, drive demand for precise synthetic methods to access unnatural variants (UAAs) and stereochemically defined peptides. We report an N-heterocyclic carbene (NHC)-catalyzed strategy enabling enantioselective synthesis of α-(U)AA esters and peptides. Leveraging NHC-generated acyl azolium intermediates, this approach achieves dynamic kinetic resolution of racemic or chiral α-(U)AAs with broad substrate scope, including sterically hindered and unsaturated derivatives. Stereodivergent synthesis is accomplished via NHC-mediated proton shuttling, which usually furnishes enantio-complementary α-(U)AAs and peptides with >90% ee (de). Mechanistic studies establish that N,N'-diisopropylcarbodiimide activates α-(U)AAs to form oxazolone intermediates, which undergo NHC-mediated conversion to acyl azolium species. Divergent nucleophilic pathways are governed by chiral matching between catalyst and substrate, as evidenced by density functional theory (DFT) calculations revealing π-π interactions and steric effects as stereoselectivity determinants. The methodology's utility is also demonstrated in solid-phase peptide synthesis, achieving direct chirality transfer from racemic precursors to peptides with minimal epimerization. This work provides a catalytic platform for stereocontrolled α-(U)AA and peptide synthesis, with implications for chemical biology and peptide therapeutic development.

Indexed as

Amino AcidsHeterocyclic CompoundsMethaneCatalysisEstersKineticsPeptidesStereoisomerismAmino AcidscarbeneEstersHeterocyclic CompoundsMethanePeptides

Identifiers

PMID41068077
PMCPMC12511568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.